期刊文献+

自杀基因治疗乳腺癌的研究进展 被引量:1

Progress in the Suicide Gene Therapy of Breast Cancer
下载PDF
导出
摘要 自杀基因疗法是近年乳腺癌基因治疗研究的热点之一。这类基因所编码的酶能将无细胞毒性或低细胞毒性的前体药转化成细胞毒性代谢产物 ,经靶向性转导或靶向性转录 ,选择性地杀伤肿瘤细胞。简要介绍该疗法的机理以及基因治疗载体。 Suicide gene therapy is based on the gene delivery or antibody delivery of a gene that encodes an enzyme converting a prodrug into a potent cytotosin.Several systems have been investigated and demonstrated effectively in tissue culture,animal models and clinical trials.This review is to summarize the progress in the strategies.
出处 《肿瘤防治杂志》 2003年第5期541-544,共4页 China Journal of Cancer Prevention and Treatment
关键词 乳腺肿瘤 乳腺癌 基因治疗 自杀基因疗法 肿瘤细胞 breast neoplasms/therapy gene therapy review literature
  • 相关文献

参考文献2

二级参考文献9

  • 1Wei M X,Cancer Res,1998年,5 8卷,16期,3529页
  • 2Hurwitz A A,Int J Cancer,1998年,7卷,1期,107页
  • 3杨木兰,现代免疫学实验技术,1997年,454页
  • 4Tischer E,Mitchell R,Hartman T,et al.The human gene for vascular endothelial growth factor.Mutiple protein forms are encoded through alternative exon splicing[].Journal of Biological Chemistry.1991
  • 5Ferrara N,Houck K,Jakem an L,et al.M olecular and biologicalproperties of the vascular endothelial grow th factor fam ily ofproteins[].Endocrine Reviews.1992
  • 6Poltorak Z,Cohen T,Srvan R,et al.VEGF-145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix[].Journal of Biological Chemistry.1997
  • 7LiottaLA,StrackeML.Tumorinvasionandmetastasis:biochemicalmechanisms[]..1988
  • 8Ohta Y,Watanabe Y,Murakami S,et al.Vascular endothelial growth factor and lymph node metastasis in primary lung cancer[].British Journal of Cancer.1997
  • 9苏宁,张晓明,韩月明,陈平圣.SHZ——88大鼠乳腺癌细胞系的建立及其生物学特性观察[J].癌症,1991,10(5):378-381. 被引量:10

共引文献70

同被引文献14

  • 1袁时芳,李开宗,王岭,颜真,韩苇,张英起.GM-CSF对MUC1基因疫苗抑制乳腺癌生长的增强作用[J].细胞与分子免疫学杂志,2004,20(6):737-740. 被引量:7
  • 2王烈,王瑜,邹忠东,姚和祥,钱其军,杨广顺,郭亚军.HSV—TK、B7联合基因治疗乳腺癌的动物实验研究[J].福州总医院学报,2000,7(4):26-28. 被引量:1
  • 3高宝东.基因治疗乳腺癌[J].临床和实验医学杂志,2007,6(4):164-165. 被引量:1
  • 4Takahashi S,Hatake K,Sugimoto Y.Gene therapy for breast cancer[J].Gan to Kagaku Ryoho,2003,30(1):468-477.
  • 5Pastorakova A,Hlubinova K,Bodo J,et al.Tumor targeted gene therapy with plasmid expressing human tumor necrosis factor alpha in vitro and in vivo[J].Neoplasma,2005,52(4):344-351.
  • 6Loudon PT,Mclean CS,Martin G,et al.Preclinical evaluation of DISC GMCSF for the treatment of breast carcinoma[J].J Gene Med,2003,5(5):407-416.
  • 7Kawakami K,Kawakami M,Puri RK.Specifically targeted killing of interleukin-13 (IL-13) receptor-expressing breast cancer by IL-13 fusion cytotoxin in animal model of human disease[J].Mol Cancer Ther,2004,3(2):137-147.
  • 8Liu Y,ChirivaInternati M,You C,et al.Use and specificitv of breast cancer antigen/miIk protein BA4b for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loadingof dendritic cells[J].Cancer Gene Ther,2005,12(3):304-312.
  • 9Chen Y,Emtage P,Zhu Q,et al.Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells:enhanced efficacy by cotransduction of gene encoding IL-12[J].Cene Ther,2001,8(4):316-323.
  • 10Sevignani C,Calin GA,Cesari R,et al.Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines[J].Cancer Res,2003,6(3):1183-1187.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部